Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
Sanofi
Type
Société Anonyme
Traded as Euronext: SAN, NYSE: SNY
Industry Pharmaceuticals
Founded 20 August 2004 (by acquisition) as Sanofi Aventis
6 May 2011 as Sanofi
Headquarters 54, rue La Boétie, 8th arrondissement, Paris, France
Key people
Olivier Brandicourt (CEO, Chairman), Jean-François Dehecq (Original Founder)
Products Prescription and over-the-counter drugs for thrombosis, cardiovascular disease, diabetes, central nervous system disorders, oncology and internal medicine, vaccines (list...)
Revenue €33.77 billion (2014)
Operating income
€6.14 billion (2014)
Profit €4.39 billion (2014)
Total assets €96.07 billion (2013)
Total equity €56.89 billion (2013)
Number of employees
112,128 (2013)
Subsidiaries Sanofi Pasteur
Genzyme
Shantha Biotechnics
Chattem
Zentiva
Medley
Nichi-Iko
Merial
Website www.sanofi.com

Sanofi S.A. is a French multinational pharmaceutical company headquartered in Paris, France, as of 2013 the world's fifth-largest by prescription sales. The company was formed as Sanofi-Aventis in 2004 by the merger of Aventis and Sanofi-Synthélabo, which were each the product of several previous mergers. It changed its name to Sanofi in May 2011.

Rorer

Centeon

Pasteur Merieux

Rhône-Poulenc Agro

Rhône-Poulenc Animal Nutrition

Merial

Rhodia

Hoechst Marion Roussel

AgrEvo

HR Vet

Dade Behring

Centeon

Celanese

Messer

Aventis Cropscience
(Spun off 2000)

Sanofi
(Founded 1973 as subsidiary of Elf Aquitaine)

Sterling Winthrop
(Acq 1994)

Laboratoires Dausse
(Founded 1834, merged 1970)

Robert & Carrière
(Founded 1899, merged 1970)

Zentiva
(Acq 2008)

Sicomed SA Bucharest
(Acq 2005)

Leciva Slovakofarma
(Acq 2003)

Medley Farma
(Acq 2009)

Shantha Biotechnics
(Acq 2009)

Chattem
(Acq 2010)

Nepentes Pharma
(Acq 2010)

BMP Sunstone Corporation
(Acq 2010)

Genzyme Corporation
(Acq 2011)

Investment goal date:
Dividends reinvested
Sanofi SNY report Q3 2017
Period
Date
Adjusted Actuals EPS
GAAP EPS
Q4 2017
2018-02-08
--
--
Q3 2017
2017-11-02
0.0000
0.0000
Q2 2017
2017-07-31
0.7400
0.5100
Q1 2017
2017-04-28
0.7500
0.5300
Q4 2016
2017-02-08
0.6700
0.2200
Q3 2016
2016-10-28
1.0000
0.7400
Q2 2016
2016-08-03
0.7400
0.4000
Q1 2016
2016-04-29
0.7400
0.4400
Q4 2015
2016-02-09
0.8200
0.1800
Q3 2015
2015-10-29
0.9000
0.6900
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
BANK OF AMERICA CORP /DE/
7531334
BERKSHIRE HATHAWAY INC
3905875
Boston Partners
8527002
BRANDES INVESTMENT PARTNERS, LP
3490226
DODGE & COX
67977413
FEDERATED INVESTORS INC /PA/
5123688
Fisher Asset Management, LLC
12615505
FMR LLC
5218634
FRANKLIN RESOURCES INC
21015485
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC
10364345
Invesco Ltd.
8304348
MACQUARIE GROUP LTD
2848520
MORGAN STANLEY
3764318
RAYMOND JAMES & ASSOCIATES
3154447
WELLS FARGO & CO/MN
4492719
Major Shareholders
Name Relationship
Total Shares
Holding stocks